Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neoforma.com, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Business-to-business e-commerce medical device marketer goes public via $91 mil. initial public offering of 7 mil. shares at $13 each. Completed on Jan. 24, the IPO was priced higher than the $8-10 per share originally anticipated (1"The Gray Sheet" Nov. 1, p. 10). Enabling users to "efficiently" and "cost-effectively" buy and sell new and used medical products online, the Santa Clara-based Internet firm's stock trades on the Nasdaq exchange under the symbol "NEOF." Proceeds from the IPO will be used "primarily for general corporate purposes, including sales and marketing, product development and working capital," the firm says. Underwriters Merrill Lynch, Bear Stearns, Robertson Stephens and William Blair have an overallotment option for approximately 1.1 mil. additional shares

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012886

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel